Navigation Links
Research gives new hope to those with rare vascular cancer
Date:8/31/2011

A specific genetic alteration has been discovered as a defining feature of epithelioid hemangioendothelioma (EHE), a rare but devastating vascular cancer. These findings have also been used to develop a new diagnostic test for this blood vessel disease.

An international research effort led by Brian Rubin, M.D., Ph.D., of Cleveland Clinic's Pathology and Laboratory Medicine Institute and Lerner Research Institute, devised an innovative approach to reveal the genetic alteration thought to cause EHE, which is considered uncommon: it comprises less than one percent of all cancers. There are approximately 100 new cases in the U.S. each year.

The genetic aberration was detected in 89 percent (42 of 47) of EHE tumor tissues examined; none of the non-EHE vascular tumors contained the anomaly. The research, published in the Aug. 31, 2011, issue of Science Translational Medicine, was done in collaboration with Cleveland Clinic's Taussig Cancer Institute.

The authors defined the genetic aberration as a "translocation" between chromosomes 1 and 3, where chromosomes 1 and 3 exchange DNA fragments in such a way that the DNA is "transposed" onto opposite chromosomes. The result is that the swapped DNA encodes a unique, fused gene that contains components from each chromosome. Since genes are translated into proteins, the result of this unique gene is a correspondingly unique protein, whose function is deduced to be oncogenic (cancer-causing).

"This finding is the beginning of a new era for patients with EHE," said Dr. Rubin. "We firmly believe that the characterization of this genetic translocation will lead to a cure for EHE patients."

Identification of translocations in cancers is critical to understanding the molecular pathways at work within cancer cells. Understanding these molecular pathways allows cancer researchers to target them with specific drugs to disrupt the cancer. Thus, finding this translocation i
'/>"/>

Contact: Dan Doron
dorond@ccf.org
216-312-0428
Lerner Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... ... launch of their new website, the Invokana Ketoacidosis Lawsuit Center . The ... serves as a resource for persons wishing to learn more about Invokana lawsuits ...
(Date:7/7/2015)... ... July 07, 2015 , ... CareSync proudly announces ... recognized by the White House as a “Champion of Change” for Precision Medicine ... Initiative, the Champions of Change program recognizes Gleason and eight other extraordinary individuals ...
(Date:7/6/2015)... ... July 07, 2015 , ... Currently, mobile testing ... of AIDS, advances in the molecular diagnostic technologies, wide availability of immunosuppressive drugs ... detection technologies and genetic engineering also open lucrative opportunities for the market players. ...
(Date:7/6/2015)... ... ... TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, which takes ... and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the app ... rooms will look like before they even start renovating.. , Whether a person is ...
(Date:7/6/2015)... ... 2015 , ... Shortly after opening her second practice in Signal Hill, Dr. ... on a lien basis. Dr. Lim had previously worked with Dr. Kevin Kelly, ... refugees, Dr. Lim suffered with back pain herself throughout high school. Unaware of ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2
... Statistical Significance, IRVINE, Calif., Oct. 30 ... Biotech, today,announced that the Phase 3 SPARC trial ... did not meet its primary,efficacy endpoint. "We ... for,satraplatin did not achieve statistical significance. Drug development ...
... of radiotherapy to treat breast cancer may, in some ... potentially toxic radiation as does the standard six weeks ... That because the short treatment, known as partial breast ... breast through multiple beams, these beams can pass through ...
... SGXP ) announced today that the company will ... Grey, president & chief,executive officer of SGX Pharmaceuticals, will ... conference information is as,follows: -- BIOCOM Investor Conference ... at 9:00 AM Pacific Daylight Time at the Marriott ...
... On Sunday, November 4,2007, Eli Lilly and Company ... with,the investment community and media to review the details ... Association,Scientific Sessions in Orlando, Florida. This call will follow ... TRITON TIMI-38 trial. The Lilly conference call will ...
... Higher Volumes, ALISO VIEJO, Calif., Oct. 30 ... technology and services resource for,pathologists, oncologists and the ... quarter ended September 30, 2007. Revenue,from continuing operations ... 2007,an increase of 52 percent compared to $7.9 ...
... 2007 4:30 p.m. EST http://www.nucryst.com , WAKEFIELD, ... a webcast at 4:30 p.m. EST on Wednesday, November ... In addition to standard disclosure over wire services, a ... NUCRYST web site. To listen,to the call live on ...
Cached Medicine News:Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 2Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 3Health News:Normal tissue not spared in new forms of breast cancer radiotherapy 2Health News:SGX Pharmaceuticals to Present at Three Upcoming Investor Conferences 2Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 2Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 3Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 4Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 5Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 6
(Date:7/6/2015)... Increase in R&D activities ... in Germany through 2020   ... report, " Germany Bioinformatics Market Forecast & Opportunities, 2020 ... is projected to register a CAGR of over 29% ... growth on account of rising government funding and initiatives, ...
(Date:7/6/2015)... -- Cardinal Health today announced the completion of the ... generic pharmaceuticals, over-the-counter medications and related products to retail, ... Court Square Capital Partners. The $1.115 billion acquisition was ... Headquartered in Livonia, Mich. ... approximately $450 million in 2014. There are 450 employees ...
(Date:7/6/2015)... , June 29, 2015 ... addition of the "Pharmaceutical Grade Sodium Chloride Market ... to 2019" report to their offering. ... witness a CAGR of 6.9% between 2014 and 2019 ... to reach 690 KT by 2019. The ...
Breaking Medicine Technology:Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... Dec. 5, 2011 The National Foundation for Infectious ... Prevention (CDC) in highlighting the importance of influenza prevention ... 10, and encouraging vaccination through the holiday season and ... steadily increased over the past few years, but many ...
... TRAB), a manufacturer and distributor of homeopathic nasal sprays for ... and migraine headaches, today announced the relocation of its corporate ... located at 4400 Route 9 South in Manalapan, New Jersey ... for the Company,s future growth. Kelly Hickel, ...
Cached Medicine Technology:National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 2National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 3National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 4TheraBiogen, Inc. Relocates Corporate Headquarters to New Jersey 2
... Humphrey Field Analyzer II-i series is a ... the patient's visual field. By using SitaTM, ... is reduced by up to 70%. A ... ergonomic design to increase patient comfort while ...
... Made Toric soft contact lenses let you enjoy ... soft toric lens in a lens custom made ... comfort is made possible by PC Technology™, which ... (PC), a substance found naturally in human cell ...
Frequency 55 Toric XR is a great option for those with high levels of astigmatism...
A low water content prism-ballasted toric soft lens manufactured using patented Toric Generating lathe-cutting technology and designed for use in the correction of astigmatism on a daily wear basis....
Medicine Products: